 |
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Purity 99% APIs Intermediates
Product Details:
| Place of Origin: | CHINA |
| Brand Name: | AK BIOTECH |
| Certification: | COA |
| Model Number: | 356783-28-3 |
Payment & Shipping Terms:
| Minimum Order Quantity: | Negotiation |
|---|---|
| Price: | Negotiation |
| Packaging Details: | Aluminum Foil Bag, barrel, or drum. |
| Delivery Time: | 7-15 working days |
| Payment Terms: | T/T |
| Supply Ability: | 100 kilograms per month |
|
Detail Information |
|||
| Product Name: | 3,6-Difluoropyrazine-2-carbonitrile | CAS No: | 356783-28-3 |
|---|---|---|---|
| Purity: | 99% | M.W: | 141.08 |
| MF: | C5HF2N3 | Synonyms: | 2-Pyrazinecarbonitrile,3,6-difluoro- |
| Highlight: | 99% Purity 3 6-Difluoropyrazine-2-carbonitrile,356783-28-3 Pharmaceutical Raw Materials,356783-28-3 Pharmaceutical Intermediates |
||
Product Description
3,6-Difluoropyrazine-2-carbonitrile CAS No356783-28-3 Purity 99%
| Name: |
3,6-Difluoropyrazine-2-carbonitrile |
| CAS No: |
356783-28-3 |
| M.W: |
141.08 |
| Appearance: |
N/A |
| Purity: |
98% |
| Synonyms: |
3,6-difluoro-2-pyrazinecarbonitrile 2-Pyrazinecarbonitrile,3,6-difluoro- |
Product description
3,6-Difluoropyrazine-2-carbonitrile (356783-28-3)has been supplied to well-known enterprises at home and abroad on an experimental scale, and its product quality has been well received, which is superior to similar products in the market and provides good support for the stable quality of downstream products.
3,6-Difluoropyrazine-2-carbonitrile (356783-28-3) is our customized product. Welcome new and old customers to inquire.
Application
3,6-Difluoropyrazine-2-carbonitrile can be used as an intermediate of pilavir.
Packing Instruction
Notice: Please notify us in advance if request for special packing.
Means of Transport
Small package(1g, 25g, 100g,1Kg,25Kg) can be ship by express. (USP, DHL, FedEx, EMS, etc.)
Large package(100kg and more than100Kg) can be transported by Air or Sea.
Of course, we will ship the goods according to the customer's opinions.
AK Biotech Profile